Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	58.45	37.79	38.52	54.84
Short-Term Investments	177.43	109.75	-	27.77
Cash & Short-Term Investments	235.88	147.54	38.52	82.61
Cash Growth	59.88%	283.01%	-53.37%	-
Prepaid Expenses	5.54	3.46	0.69	1.22
Total Current Assets	241.42	150.99	39.21	83.83
Property, Plant & Equipment	9.15	10.3	11.62	1.79
Long-Term Investments	74.42	20.51	-	-
Other Long-Term Assets	0.96	3.96	1.12	1.74
Total Assets	325.95	185.75	51.95	87.37
Accounts Payable	0.77	1.19	0.72	0.56
Accrued Expenses	9.67	7.67	6.59	7.7
Current Portion of Leases	1.27	1.07	0.73	-
Other Current Liabilities	0.01	0.49	-	-
Total Current Liabilities	11.71	10.42	8.04	8.25
Long-Term Leases	7.41	8.68	9.75	-
Total Liabilities	19.12	19.1	17.79	8.25
Common Stock	0.05	0.01	0	0
Additional Paid-In Capital	562.6	17	4.52	2.23
Retained Earnings	-256.35	-181.09	-119.4	-72.14
Comprehensive Income & Other	0.54	0.37	-	-0.02
Total Common Equity	306.83	-163.71	-114.88	-69.92
Shareholders' Equity	306.83	166.66	34.16	79.12
Total Liabilities & Equity	325.95	185.75	51.95	87.37
Total Debt	8.68	9.75	10.48	-
Net Cash (Debt)	301.63	158.29	28.04	82.61
Net Cash Growth	90.55%	464.45%	-66.05%	-
Net Cash Per Share	7.55	41.02	9.56	32.05
Filing Date Shares Outstanding	45	44.12	3.05	2.58
Total Common Shares Outstanding	44.72	4.72	3.05	2.58
Working Capital	229.71	140.57	31.17	75.58
Book Value Per Share	6.86	-34.66	-37.66	-27.13
Tangible Book Value	306.83	-163.71	-114.88	-69.92
Tangible Book Value Per Share	6.86	-34.66	-37.66	-27.13
Machinery	2.43	2.18	2.05	0.62
Construction In Progress	-	-	-	1.52
Leasehold Improvements	1.92	1.85	1.85	-

Source: S&P Capital IQ. Standard template. Financial Sources.